Increased collagenase activity in macrophages from bronchial lavage as a diagnostic marker of non-small cell lung cancer
- PMID: 12554893
- PMCID: PMC1746584
- DOI: 10.1136/thorax.58.2.122
Increased collagenase activity in macrophages from bronchial lavage as a diagnostic marker of non-small cell lung cancer
Abstract
Background: The roles of matrix metalloproteinases (MMPs) in cancer metastasis have been studied. Macrophages are considered to release MMPs in the tissues of patients with lung cancer.
Methods: Intracellular collagenase activity was measured in CD14+ CD45+ cells from bronchial lavage fluid to establish a new diagnostic tool for lung cancer. Between August 2000 and November 2001 bronchoscopy and bronchial lavage were performed in 45 patients with abnormal shadows on the chest radiograph; 21 had lung cancer and 24 had non-malignant disease.
Results: Collagenase activity in patients with primary lung cancer (5.54 (0.65)) or non-small cell lung cancer (NSCLC) (5.62 (0.71)) was significantly higher than in those with non-malignant disease (3.63 (0.78), p=0.006 and p=0.008, respectively). Only three of 18 patients in the low activity group were diagnosed as having cancer compared with 18 of 27 in the high activity group (p=0.001). This significance was not seen in non-smokers but it was apparent in smokers/ex-smokers. Excluding non-smokers improved the specificity of collagenase activity in differentiating cancer and non-malignant disease from 62.5% to 80.0%. The sensitivity of the test was 85.7% in all patients and 88.2% in smokers/ex-smokers.
Conclusions: Measurement of intracellular collagenase activity in macrophages in bronchial lavage fluid is a useful diagnostic tool for distinguishing between cancer and non-malignant diseases, especially in smokers and ex-smokers.
Similar articles
-
Paradoxically decreased intracellular collagenase activity in macrophages from bronchoalveolar lavage fluid in current smokers and patients with obstructive ventilatory disorder.Int J Mol Med. 2004 Jun;13(6):859-63. Int J Mol Med. 2004. PMID: 15138625
-
Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer.Tumori. 2006 Mar-Apr;92(2):149-54. doi: 10.1177/030089160609200211. Tumori. 2006. PMID: 16724695
-
Surfactant protein D and bronchial dysplasia in smokers at high risk of lung cancer.Chest. 2008 Sep;134(3):582-588. doi: 10.1378/chest.08-0600. Chest. 2008. PMID: 18779194
-
Extracellular matrix metalloproteinase inducer is increased in smokers' bronchoalveolar lavage fluid.Am J Respir Crit Care Med. 2003 Jul 15;168(2):222-7. doi: 10.1164/rccm.200301-103OC. Epub 2003 Apr 24. Am J Respir Crit Care Med. 2003. PMID: 12714350
-
Comparison of elastolytic activity in lung lavage from current, ex- and non-smokers.Life Sci. 1988;43(5):459-64. doi: 10.1016/0024-3205(88)90526-7. Life Sci. 1988. PMID: 2456443
Cited by
-
Lipid-Laden Macrophages in Pulmonary Diseases.Cells. 2024 May 22;13(11):889. doi: 10.3390/cells13110889. Cells. 2024. PMID: 38891022 Free PMC article. Review.
-
Efficacy and selectivity of nilotinib on NF1-associated tumors in vitro.J Neurooncol. 2014 Jan;116(2):231-6. doi: 10.1007/s11060-013-1295-z. Epub 2013 Oct 31. J Neurooncol. 2014. PMID: 24173684
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous